These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12605877)

  • 21. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
    Christen Y
    J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intercellular Spread of Protein Aggregates in Neurodegenerative Disease.
    Davis AA; Leyns CEG; Holtzman DM
    Annu Rev Cell Dev Biol; 2018 Oct; 34():545-568. PubMed ID: 30044648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in our understanding of neurodegeneration.
    Jellinger KA
    J Neural Transm (Vienna); 2009 Sep; 116(9):1111-62. PubMed ID: 19707851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Looking backward to move forward: early detection of neurodegenerative disorders.
    DeKosky ST; Marek K
    Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function.
    Leighton PL; Allison WT
    J Alzheimers Dis; 2016 Jul; 54(1):3-29. PubMed ID: 27392869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.
    Forman MS; Trojanowski JQ; Lee VM
    Nat Med; 2004 Oct; 10(10):1055-63. PubMed ID: 15459709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein folding diseases and neurodegeneration: lessons learned from yeast.
    Winderickx J; Delay C; De Vos A; Klinger H; Pellens K; Vanhelmont T; Van Leuven F; Zabrocki P
    Biochim Biophys Acta; 2008 Jul; 1783(7):1381-95. PubMed ID: 18298958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
    Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H
    Neuropharmacology; 2003 Jul; 45(1):14-44. PubMed ID: 12814657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid deposits: protection against toxic protein species?
    Treusch S; Cyr DM; Lindquist S
    Cell Cycle; 2009 Jun; 8(11):1668-74. PubMed ID: 19411847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sour side of neurodegenerative disorders: the effects of protein glycation.
    Vicente Miranda H; Outeiro TF
    J Pathol; 2010 May; 221(1):13-25. PubMed ID: 20186922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodegenerative disease: amyloid pores from pathogenic mutations.
    Lashuel HA; Hartley D; Petre BM; Walz T; Lansbury PT
    Nature; 2002 Jul; 418(6895):291. PubMed ID: 12124613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic classification of primary neurodegenerative disease.
    Hardy J; Gwinn-Hardy K
    Science; 1998 Nov; 282(5391):1075-9. PubMed ID: 9804538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keystone symposium, Neurodegenerative Diseases: New Molecular Mechanisms 17-22 February 2009.
    Fagan T
    J Alzheimers Dis; 2009; 17(4):939-50. PubMed ID: 19641252
    [No Abstract]   [Full Text] [Related]  

  • 37. Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
    Jankowsky JL; Savonenko A; Schilling G; Wang J; Xu G; Borchelt DR
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):457-64. PubMed ID: 12169227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of the neurodegenerative disorders.
    Martin JB
    N Engl J Med; 1999 Jun; 340(25):1970-80. PubMed ID: 10379022
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein aggregation and prionopathies.
    Renner M; Melki R
    Pathol Biol (Paris); 2014 Jun; 62(3):162-8. PubMed ID: 24698014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
    Hague SM; Klaffke S; Bandmann O
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1058-63. PubMed ID: 16024878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.